Skip to main content
. 2017 Jun 16;8(34):57012–57023. doi: 10.18632/oncotarget.18505

Figure 1. Expression of miR-107-5p decreases in NSCLC.

Figure 1

(A) Expression of miR-107-5p in NSCLC and corresponding non-tumor tissues (n = 61). (B) Expression of miR-107-5p in the human NSCLC cell lines and BEAS-2B (normal control) was measured by qRT-PCR (*P < 0.05, **P < 0.01, ***P < 0.001).